
Astorg promotes Le Baron and Veber to partner
Global private equity firm Astorg has promoted two partners, Charles-Hubert Le Baron and Thibault Veber.
Le Baron joined Astorg as an analyst in 2011, while Veber joined as an associate director in 2017.
The private equity firm has more than EUR 15bn in assets under management.
Le Baron has worked on Astorg's exit of HRA Pharma, a French consumer self-care company, to listed firm Perrigo in September 2021, as well as its EUR 1bn trade sale of M7 Group to Canal+.
In 2015, he worked on Carlyle's EUR 560m SBO of bottle manufacturer Saverglass, and, in 2017, the EUR 2bn exit of Sebia.
Le Baron also participated in the launch of Astorg's Mid-Cap Fund in 2020, where he now leads the sourcing effort in France and Benelux.
Prior to Astorg, he spent two years with EY in Paris on the transaction advisory team.
Veber heads up the capital markets team in London. He is responsible for leading acquisition financings and follow-ons, and fund-level transactions, as well as managing the firm's relationships with lenders.
Recent deals that he has worked on include Astorg's 2020 acquisition of Normec, its March 2021 buyout of Opus 2, and its SBO of Coralis from CVC.
Veber has generalised the use of ESG-friendly loans among portfolio companies.
Prior to Astorg, he worked on leveraged finance at Nomura and Citigroup in London, focusing on European loan and high-yield transactions.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater